Mundial S.A. - Produtos de Consumo (BVMF:MNDL3)
17.50
-0.72 (-3.95%)
Aug 7, 2025, 12:52 PM GMT-3
Revance Therapeutics Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.